Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-486-2 | CAS number: 3115-49-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Assessment of the toxicokinetic behavior
No studies are available investigating the toxicokinetic properties of the test substance. The test substance (molecular weight of 278.4 g/mol) is a clear, yellow to brown viscous liquid (BASF, 2012) with a water solubility of 0.04 g/L (Ciba-Geigy, 1985) and a vapor pressure of 0.0025 Pa at 25°C (Ciba-Geigy, 1985). The log Pow was calculated to be 5.8 for the neutral, undissoziated form (EPI Suite, BASF, 2012), and is further characterized by pH dependency, ranging from 4.6 at pH 4 to 1.7 at pH 9 (SciFinder, 2011).
Absorption
Absorption via the gastrointestinal tract:
Absorption through the gastrointestinal tract is favored for molecules with a molecular weight below 500 g/mol (ECHA GD 7c, 2008), thus the test article’s molecular weight is favorable for absorption after oral exposure. Further criteria in favor of absorption are hydrophilicity and a moderate log POW value (between -1 and 4). The test article is hydrophobic and therefore not very soluble in aqueous solutions. However, the moderate log P of the test article at physiological conditions is in favor of absorption. In a combined 28-day repeated dose toxicity study with the reproduction/developmental toxicity screening test in rats, treatment with the test item caused systemic effects in the high dose group. The weights of liver and thyroid glands were increased and kidneys in males were increased slightly. In conclusion, gastrointestinal absorption takes place as shown by the in vivo data obtained in the repeated dose study.
Dermal absorption:
Dermal uptake is favored for chemicals with a molecular weight < 100 g/mol, while for chemicals with a molecular weight > 500 g/mol, dermal uptake is not favored (ECHA GD 7c,2008). In addition, Log P values between 1 and 4 favor dermal absorption. Given the corrosive nature of the test article, uptake after dermal exposure is expected to be increased due to the damage of dermal tissue. This is in line with the results obtained in a guinea pig maximization test. Here, the test article was shown to cause skin sensitization after dermal exposure, indicating its potential to cross the dermal barrier.
Absorption via inhalation:
No experimental data from acute or repeated dose inhalation toxicity studies are available, which could provide information about the systemic distribution of the test substance after inhalation. The test article is a liquid with a low vapor pressure; therefore its availability for inhalation is expected to be low.
Metabolism
In an Ames and an HPRT test, the test article did not produce an increase in revertant colonies in the presence of a metabolizing agent, therefore no conclusion can be drawn regarding in vitro metabolization. In the available repeated dose toxicity study increases in liver and kidney weights were observed in high dose animals. This often correlates with an increased workload due to administration of the test article indicating that the test article is metabolized in the liver. However, the test article also caused increases in thyroid gland weights and disturbance of T4 levels, which might be due to a rat specific enzyme induction in the liver.
Excretion
Smaller molecules (< 300 g/mol) tend to be excreted in the urine, especially when they are soluble in water. Larger molecules are expected to be eliminated via biliary excretion. The test substance has a molecular weight of < 300, therefore allowing for excretion via the urine. However, this pathway might be limited by the low water solubility, therefore excretion might occur via feces. Potential metabolites might be excreted via urine or feces, depending on size and water solubility after metabolic breakdown and phase II metabolism.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
